Brazil Plans Public Consultation on E-Cigarette Regulation

Regulations by 2FIRSTS.ai
Jun.28.2023
Brazil Plans Public Consultation on E-Cigarette Regulation
Brazil's National Health Surveillance Agency (Anvisa) plans to begin a public consultation on e-cigarette regulation later this year.

According to Brazilian media outlet Metrópoles, the Brazilian National Health Surveillance Agency (Anvisa) is planning to seek public input regarding the regulation of e-cigarettes in the latter half of this year.

 

Antonio Barra Torres, President of Anvisa, revealed that the public consultation process is still in the formulation stage.

 

Currently, Brazil has imposed a ban on the sale, import, and distribution of e-cigarettes. Those who violate the regulations may face fines of up to 1.5 million Brazilian reais (approximately 2.25 million Chinese yuan).

 

During the public consultation period, various social and economic stakeholders involved in this issue will have the opportunity to submit their opinions, suggestions, and criticisms to the organization.

 

According to a study conducted by research institution Ipec, the number of e-cigarette users in Brazil has grown from 500,000 to 2.2 million. In the capital city of Brasília, approximately 4% of the population now uses e-cigarettes.

 

The Brazilian government loses 2.2 billion Brazilian Real (approximately 3.1 billion Chinese Yuan) annually due to untaxed illegal products, leading to a loss of 110,000 employment opportunities for the country.

 

British American Tobacco (BAT) and Philip Morris International (PMI) have both expressed their views on e-cigarette regulation in Brazil. Lauro Anhezini Jr, the Head of Science and Regulatory Affairs for BAT Brazil, stated:

 

"If more harmful cigarettes can be legally sold, BAT cannot understand why e-cigarettes are banned in this country, considering that over 80 countries have regulated them. Compared to traditional cigarettes, their risk is reduced by 95%."

 

BAT has expressed plans to expand its existing factory to accommodate the production of e-cigarettes, initially using imported components for e-cigarette assembly. PMI representatives have stated that if Brazil's National Health Surveillance Agency lifts the ban on e-cigarettes and heated tobacco products, PMI will plan to build a new factory in Rio Grande do Sul, a city in southern Brazil.

 

Reference:

 

【1】O próximo passo para a Anvisa regular cigarros eletrônicos

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY announced VIZ on May 6, 2026, describing it as the brand’s first product with a transparent 360-degree wraparound pod.
May.07 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea’s Ministry of Finance and Economy said on May 4 that it requested the Daejeon Metropolitan Police Agency and Gyeonggi Nambu Provincial Police Agency to investigate three sales companies on suspicion of violating the Tobacco Business Act.
May.06 by 2FIRSTS.ai
PMI Sells Stake in Swedish Match Brazil Business, Including Fiat Lux Brand
PMI Sells Stake in Swedish Match Brazil Business, Including Fiat Lux Brand
Philip Morris International said it is selling its stake in Swedish Match do Brasil, which controls the Brazilian household goods brand Fiat Lux. The buyer is Ignis FIP, a Brazilian private investment vehicle backed by businessman Marcos Fernando Garms. The transaction also includes Swedish Match da Amazônia, but the value of the deal was not disclosed. PMI said the sale is aligned with its vision of a smoke-free future.
Mar.20 by 2FIRSTS.ai
Virginia Attorney General Backs Vape Enforcement Act Limiting Sales to FDA-Authorized or Pending Products
Virginia Attorney General Backs Vape Enforcement Act Limiting Sales to FDA-Authorized or Pending Products
Virginia Attorney General Jay Jones is backing new vape enforcement legislation that he said would do more than warn people about the dangers of vaping. The proposal would tighten rules on which products can be sold and increase enforcement aimed at keeping vapes out of the hands of young people.
Mar.24 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai